Today, 85 years after its foundation, Corporación Farmacéutica Recalcine is the leading company in the pharmaceutical market in Chile. It is constantly developing biotechnology projects and clinical studies, supported by the main forming entities in Chile and abroad.
Corporación Farmacéutica Recalcine inaugurated in September 2006 the CFR Pharmafuturo Pharmaceutical Complex, with the purpose to become the first Latin American laboratory with a global presence and research of its own. CFR Pharmafuturo Pharmaceutical Complex was designed according to the GMP (Good Manufacturing Practice)
Seafood labelling campaign raises controversial views Australia
Several conservationists, scientists, fishermen and fish-lovers have teamed up to urge Australian authorities to follow the EU on seafood labelling laws whereas certain caterers and importers question the move.